Household & Personal Products
Compare Stocks
5 / 10Stock Comparison
PG vs UL vs KMB vs CL vs CHD
Revenue, margins, valuation, and 5-year total return — side by side.
Household & Personal Products
Household & Personal Products
Household & Personal Products
Household & Personal Products
PG vs UL vs KMB vs CL vs CHD — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Household & Personal Products | Household & Personal Products | Household & Personal Products | Household & Personal Products | Household & Personal Products |
| Market Cap | $338.64B | $127.64B | $32.26B | $69.26B | $22.15B |
| Revenue (TTM) | $86.72B | $120.06B | $16.54B | $20.38B | $6.21B |
| Net Income (TTM) | $12.72B | $12.20B | $2.12B | $2.13B | $733M |
| Gross Margin | 50.3% | 71.3% | 35.9% | 60.1% | 45.1% |
| Operating Margin | 23.2% | 15.8% | 13.3% | 21.3% | 17.3% |
| Forward P/E | 21.0x | 18.5x | 12.9x | 22.6x | 24.9x |
| Total Debt | $35.46B | $30.66B | $7.17B | $7.99B | $2.21B |
| Cash & Equiv. | $9.56B | $6.14B | $688M | $1.29B | $409M |
PG vs UL vs KMB vs CL vs CHD — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| The Procter & Gambl… (PG) | 100 | 125.0 | +25.0% |
| Unilever PLC (UL) | 100 | 108.1 | +8.1% |
| Kimberly-Clark Corp… (KMB) | 100 | 68.7 | -31.3% |
| Colgate-Palmolive C… (CL) | 100 | 119.4 | +19.4% |
| Church & Dwight Co.… (CHD) | 100 | 124.6 | +24.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: PG vs UL vs KMB vs CL vs CHD
Each card shows where this stock fits in a portfolio — not just who wins on paper.
PG carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 36 yrs, beta 0.10, yield 2.8%
- 120.1% 10Y total return vs CHD's 117.3%
- PEG 3.75 vs UL's 13.53
- Lower P/E (21.0x vs 24.9x)
UL is the #2 pick in this set and the best alternative if growth exposure and sleep-well-at-night is your priority.
- Rev growth 1.9%, EPS growth -10.5%, 3Y rev CAGR 5.0%
- Lower volatility, beta 0.05, current ratio 0.76x
- Beta 0.05, yield 3.4%, current ratio 0.76x
- 1.9% revenue growth vs KMB's -14.2%
KMB lags the leaders in this set but could rank higher in a more targeted comparison.
Among these 5 stocks, CL doesn't own a clear edge in any measured category.
CHD ranks third and is worth considering specifically for momentum.
- +2.1% vs KMB's -21.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 1.9% revenue growth vs KMB's -14.2% | |
| Value | Lower P/E (21.0x vs 24.9x) | |
| Quality / Margins | 14.7% margin vs UL's 10.2% | |
| Stability / Safety | Beta 0.05 vs KMB's 0.14, lower leverage | |
| Dividends | 2.8% yield, 36-year raise streak, vs KMB's 5.1% | |
| Momentum (1Y) | +2.1% vs KMB's -21.9% | |
| Efficiency (ROA) | 16.0% ROA vs CHD's 8.2%, ROIC 15.3% vs 13.9% |
PG vs UL vs KMB vs CL vs CHD — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
PG vs UL vs KMB vs CL vs CHD — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
PG leads in 1 of 6 categories
UL leads 1 • CHD leads 1 • KMB leads 0 • CL leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
PG leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
UL is the larger business by revenue, generating $120.1B annually — 19.3x CHD's $6.2B. Profitability is closely matched — net margins range from 14.7% (PG) to 10.2% (UL). On growth, PG holds the edge at +7.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $86.7B | $120.1B | $16.5B | $20.4B | $6.2B |
| EBITDAEarnings before interest/tax | $21.9B | $21.7B | $2.8B | $3.9B | $1.3B |
| Net IncomeAfter-tax profit | $12.7B | $12.2B | $2.1B | $2.1B | $733M |
| Free Cash FlowCash after capex | $15.0B | $14.5B | $2.6B | $3.6B | $1.1B |
| Gross MarginGross profit ÷ Revenue | +50.3% | +71.3% | +35.9% | +60.1% | +45.1% |
| Operating MarginEBIT ÷ Revenue | +23.2% | +15.8% | +13.3% | +21.3% | +17.3% |
| Net MarginNet income ÷ Revenue | +14.7% | +10.2% | +12.8% | +10.5% | +11.8% |
| FCF MarginFCF ÷ Revenue | +17.3% | +12.1% | +15.6% | +17.8% | +17.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | +7.4% | -3.2% | -14.0% | +5.8% | +0.1% |
| EPS Growth (YoY)Latest quarter vs prior year | +5.8% | -3.4% | +17.6% | -105.1% | +2.2% |
Valuation Metrics
UL leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 16.0x trailing earnings, KMB trades at a 51% valuation discount to CL's 32.8x P/E. Adjusting for growth (PEG ratio), PG offers better value at 3.98x vs UL's 16.00x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $338.6B | $127.6B | $32.3B | $69.3B | $22.2B |
| Enterprise ValueMkt cap + debt − cash | $364.5B | $156.3B | $38.7B | $76.0B | $24.0B |
| Trailing P/EPrice ÷ TTM EPS | 22.26x | 21.83x | 16.01x | 32.83x | 30.97x |
| Forward P/EPrice ÷ next-FY EPS est. | 20.97x | 18.46x | 12.93x | 22.61x | 24.91x |
| PEG RatioP/E ÷ EPS growth rate | 3.98x | 16.00x | — | — | — |
| EV / EBITDAEnterprise value multiple | 15.65x | 11.99x | 12.48x | 15.26x | 18.08x |
| Price / SalesMarket cap ÷ Revenue | 4.02x | 1.80x | 1.87x | 3.40x | 3.57x |
| Price / BookPrice ÷ Book value/share | 6.80x | 5.56x | 19.60x | 191.84x | 5.71x |
| Price / FCFMarket cap ÷ FCF | 24.11x | 14.04x | 19.69x | 19.06x | 20.27x |
Profitability & Efficiency
CHD leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
CL delivers a 2.5% return on equity — every $100 of shareholder capital generates $3 in annual profit, vs $17 for CHD. CHD carries lower financial leverage with a 0.55x debt-to-equity ratio, signaling a more conservative balance sheet compared to CL's 21.88x. On the Piotroski fundamental quality scale (0–9), CHD scores 7/9 vs KMB's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +23.8% | +61.2% | +131.7% | +2.5% | +17.4% |
| ROA (TTM)Return on assets | +10.0% | +16.0% | +12.5% | +12.5% | +8.2% |
| ROICReturn on invested capital | +20.1% | +15.3% | +23.3% | +43.4% | +13.9% |
| ROCEReturn on capital employed | +23.0% | +17.7% | +25.3% | +41.6% | +14.4% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 5 | 5 | 6 | 7 |
| Debt / EquityFinancial leverage | 0.68x | 1.36x | 4.34x | 21.88x | 0.55x |
| Net DebtTotal debt minus cash | $25.9B | $24.5B | $6.5B | $6.7B | $1.8B |
| Cash & Equiv.Liquid assets | $9.6B | $6.1B | $688M | $1.3B | $409M |
| Total DebtShort + long-term debt | $35.5B | $30.7B | $7.2B | $8.0B | $2.2B |
| Interest CoverageEBIT ÷ Interest expense | 487.21x | 20.96x | 9.67x | 12.37x | 15.59x |
Total Returns (Dividends Reinvested)
Evenly matched — PG and UL and CHD each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in PG five years ago would be worth $12,310 today (with dividends reinvested), compared to $8,939 for KMB. Over the past 12 months, CHD leads with a +2.1% total return vs KMB's -21.9%. The 3-year compound annual growth rate (CAGR) favors UL at 5.3% vs KMB's -8.3% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +3.7% | -9.3% | -2.9% | +12.5% | +13.5% |
| 1-Year ReturnPast 12 months | -6.1% | -4.4% | -21.9% | -2.6% | +2.1% |
| 3-Year ReturnCumulative with dividends | +0.7% | +16.7% | -22.9% | +14.6% | -0.6% |
| 5-Year ReturnCumulative with dividends | +23.1% | +17.2% | -10.6% | +18.2% | +12.2% |
| 10-Year ReturnCumulative with dividends | +120.1% | +74.7% | +11.0% | +46.2% | +117.3% |
| CAGR (3Y)Annualised 3-year return | +0.2% | +5.3% | -8.3% | +4.7% | -0.2% |
Risk & Volatility
Evenly matched — CL and CHD each lead in 1 of 2 comparable metrics.
Risk & Volatility
CL is the less volatile stock with a -0.00 beta — it tends to amplify market swings less than KMB's 0.14 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CHD currently trades 88.2% from its 52-week high vs KMB's 67.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.10x | 0.05x | 0.14x | -0.00x | 0.14x |
| 52-Week HighHighest price in past year | $170.99 | $74.98 | $144.31 | $99.33 | $106.04 |
| 52-Week LowLowest price in past year | $137.62 | $54.95 | $92.42 | $74.55 | $81.33 |
| % of 52W HighCurrent price vs 52-week peak | +84.8% | +77.9% | +67.4% | +86.9% | +88.2% |
| RSI (14)Momentum oscillator 0–100 | 43.4 | 48.5 | 42.3 | 50.1 | 41.6 |
| Avg Volume (50D)Average daily shares traded | 7.3M | 4.6M | 4.8M | 5.6M | 1.9M |
Analyst Outlook
Evenly matched — PG and KMB each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: PG as "Buy", UL as "Hold", KMB as "Hold", CL as "Hold", CHD as "Buy". Consensus price targets imply 13.2% upside for KMB (target: $110) vs 6.5% for CHD (target: $100). For income investors, KMB offers the higher dividend yield at 5.13% vs CHD's 1.26%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Hold | Hold | Buy |
| Price TargetConsensus 12-month target | $161.88 | $65.55 | $110.00 | $93.70 | $99.60 |
| # AnalystsCovering analysts | 52 | 35 | 31 | 45 | 34 |
| Dividend YieldAnnual dividend ÷ price | +2.8% | +3.4% | +5.1% | +2.6% | +1.3% |
| Dividend StreakConsecutive years of raises | 36 | 0 | 27 | 5 | 23 |
| Dividend / ShareAnnual DPS | $4.02 | $1.72 | $4.98 | $2.25 | $1.18 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.9% | +1.4% | +0.4% | +1.7% | +4.1% |
PG leads in 1 of 6 categories (Income & Cash Flow). UL leads in 1 (Valuation Metrics). 3 tied.
PG vs UL vs KMB vs CL vs CHD: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is PG or UL or KMB or CL or CHD a better buy right now?
For growth investors, Unilever PLC (UL) is the stronger pick with 1.
9% revenue growth year-over-year, versus -14. 2% for Kimberly-Clark Corporation (KMB). Kimberly-Clark Corporation (KMB) offers the better valuation at 16. 0x trailing P/E (12. 9x forward), making it the more compelling value choice. Analysts rate The Procter & Gamble Company (PG) a "Buy" — based on 52 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — PG or UL or KMB or CL or CHD?
On trailing P/E, Kimberly-Clark Corporation (KMB) is the cheapest at 16.
0x versus Colgate-Palmolive Company at 32. 8x. On forward P/E, Kimberly-Clark Corporation is actually cheaper at 12. 9x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: The Procter & Gamble Company wins at 3. 75x versus Unilever PLC's 13. 53x.
03Which is the better long-term investment — PG or UL or KMB or CL or CHD?
Over the past 5 years, The Procter & Gamble Company (PG) delivered a total return of +23.
1%, compared to -10. 6% for Kimberly-Clark Corporation (KMB). Over 10 years, the gap is even starker: PG returned +120. 1% versus KMB's +11. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — PG or UL or KMB or CL or CHD?
By beta (market sensitivity over 5 years), Colgate-Palmolive Company (CL) is the lower-risk stock at -0.
00β versus Kimberly-Clark Corporation's 0. 14β — meaning KMB is approximately -3332% more volatile than CL relative to the S&P 500. On balance sheet safety, Church & Dwight Co. , Inc. (CHD) carries a lower debt/equity ratio of 55% versus 22% for Colgate-Palmolive Company — giving it more financial flexibility in a downturn.
05Which is growing faster — PG or UL or KMB or CL or CHD?
By revenue growth (latest reported year), Unilever PLC (UL) is pulling ahead at 1.
9% versus -14. 2% for Kimberly-Clark Corporation (KMB). On earnings-per-share growth, the picture is similar: Church & Dwight Co. , Inc. grew EPS 27. 4% year-over-year, compared to -25. 1% for Colgate-Palmolive Company. Over a 3-year CAGR, UL leads at 5. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — PG or UL or KMB or CL or CHD?
The Procter & Gamble Company (PG) is the more profitable company, earning 19.
0% net margin versus 9. 5% for Unilever PLC — meaning it keeps 19. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PG leads at 24. 3% versus 14. 5% for KMB. At the gross margin level — before operating expenses — UL leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is PG or UL or KMB or CL or CHD more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, The Procter & Gamble Company (PG) is the more undervalued stock at a PEG of 3. 75x versus Unilever PLC's 13. 53x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Kimberly-Clark Corporation (KMB) trades at 12. 9x forward P/E versus 24. 9x for Church & Dwight Co. , Inc. — 12. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for KMB: 13. 2% to $110. 00.
08Which pays a better dividend — PG or UL or KMB or CL or CHD?
All stocks in this comparison pay dividends.
Kimberly-Clark Corporation (KMB) offers the highest yield at 5. 1%, versus 1. 3% for Church & Dwight Co. , Inc. (CHD).
09Is PG or UL or KMB or CL or CHD better for a retirement portfolio?
For long-horizon retirement investors, Colgate-Palmolive Company (CL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
00), 2. 6% yield). Both have compounded well over 10 years (CL: +46. 2%, KMB: +11. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between PG and UL and KMB and CL and CHD?
Both stocks operate in the Consumer Defensive sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: PG is a large-cap quality compounder stock; UL is a mid-cap income-oriented stock; KMB is a mid-cap deep-value stock; CL is a mid-cap quality compounder stock; CHD is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.